Cromsource's Paris Office to service 'flourishing French Pharma'

By Dan Stanton

- Last updated on GMT

Related tags: Contract research organization

Cromsource opens office in Paris
Cromsource opens office in Paris
Cromsource has opened offices in Paris in response to the growth of pharma R&D which is flourishing under French Government incentives, the company says.

The Italian contract research organisation (CRO) officially opened its Paris, France office last week, offering its full range of services to French clients.

“Our business is growing in France and as a result we require a greater presence there,”​ Cromsource’s Global Head of Medical Division Christian Milla told

“The med-tech and biotechnology/small-to-mid sized pharma aspects of the life science industry are burgeoning in France,”​ he said. “These are areas where Cromsource excels and our business is growing as a result.”

The company also said the growth of biopharma was due in part to incentives from the French Government, which, in turn, has led to greater demand for outsourcing partners such as itself.

Milla explained: “One of the main factors of competitiveness for the BioPharma industry in France is the Research Tax Credit, in force for a few years. Biopharma companies can obtain a tax deduction for 30 % of their R&D expenses up to €100m ($136m) which is an advantage for Biotech and Medtech startups, and small and medium enterprises.”

Furthermore, “beyond €100m of R&D expenses, the tax deduction is about 5% which is a significant advantage for Specialty and Big Pharmas established in France.”

Such expenses considered include clinical trials and, critically for Cromsource, outsourcing to CROs which Milla said “have allowed the growth of Bioclusters in France where Biotech companies have developed products which now at the clinical stage.”

France’s Research Tax Credit is, according to Science journal​, one of the most generous R&D tax breaks in the world. Furthermore this incentive remained largely untouched during last month’s budget which saw the country try to alleviate its fiscal issues with increased taxes worth €3bn and public spending debts of €15bn.

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us


View more